ARTIOS Phase IIIb, open-label, single-arm, prospective study showed a substantial reduction in disease activity in people with relapsing multiple sclerosis (RMS)following switch to Kesimpta after ...
Organize your messy digital life with AI tools. Learn how Claude, Notion 3.0, and n8n can automate emails, files, and tasks – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback